Компания XM не предоставляет услуги резидентам Соединенных штатов Америки.
I
I

Illumina


Новости

Valueact Holdings Dissolves Share Stake In Illumina; Cuts Share Stake In KKR & CO

BRIEF-Valueact Holdings Dissolves Share Stake In Illumina; Cuts Share Stake In KKR & CO Aug 14 (Reuters) - Valueact Holdings LP: VALUEACT HOLDINGS DISSOLVES SHARE STAKE IN ILLUMINA INC VALUEACT HOLDINGS, L.P. CUTS SHARE STAKE IN KKR & CO INC BY 36.6% TO 1.2 MILLION SHARES VALUEACT HOLDINGS, L.P. RAISES SHARE STAKE IN SALESFORCE INC BY 12.3% TO 3.9 MILLION SHARES VALUEACT HOLDINGS CUTS SHARE STAKE IN FISERV INC BY 69.8% TO 1.1 MILLION SHARES VALUEACT HOLDINGS, L.P.
I
S

Cancer test maker Grail rises on job cuts

BUZZ-Cancer test maker Grail rises on job cuts ** Shares of cancer diagnostic test maker Grail GRAL.O rise 11% to $17.60 premarket ** Grail late on Tuesday said it has cut existing headcount and planned hires for 2024 by about 30%, or about 350 existing jobs, as part of a restructuring plan ** Says co plans to focus on development of its flagship cancer-detection test Galleri and substantially reduce investment in product programs beyond Galleri ** Galleri is a blood test designed to detect more
I

Grail climbs on job cuts

BUZZ-Grail climbs on job cuts ** Shares of cancer test maker Grail GRAL.O rise ~13.1% to $17.92 aftermarket ** Co says it cut 350 jobs as part of a restructuring program ** Says it will focus on the development of its flagship cancer-detection blood test Galleri ** Co expects these cost reductions to extend its existing cash runway from the second
I

Cancer test maker Grail cuts 350 jobs as part of restructuring program

UPDATE 2-Cancer test maker Grail cuts 350 jobs as part of restructuring program Adds share movement in paragraph 1, background in paragraphs 6-8, quarterly results in paragraph 9 Aug 13 (Reuters) - Grail Inc GRAL.O said on Tuesday it has cut about 350 existing jobs as the diagnostics company focuses on the development of its flagship cancer-detection test Galleri, sending its shares up more than 11% in extended trading.
I

Grail to cut jobs, planned hires for 2024 by about 30%

Grail to cut jobs, planned hires for 2024 by about 30% Aug 13 (Reuters) - Cancer test maker Grail GRAL.O said on Tuesday it would reduce existing headcount and planned hires for 2024 by about 30%, as part of its restructuring program. Reporting by Christy Santhosh; Editing by Shilpi Majumdar
I

Illumina, pioneer Broad Institute to work on new gene sequencing kits

Illumina, CRISPR-pioneer Broad Institute to work on new gene sequencing kits Aug 13 (Reuters) - Illumina ILMN.O said on Tuesday it has partnered with the Broad Institute to develop new kits that will allow large-scale gene sequencing using a novel method based on the Nobel Prize-winning CRISPR technology. In a separate partnership with Broad Institute and Harvard, San Diego-based Illumina will work on research sequencing of single cells and conduct experiments using technology from the company's
I

U.S. STOCKS Abbott Laboratories, Medtronic, Axon

BUZZ-U.S. STOCKS ON THE MOVE-Abbott Laboratories, Medtronic, Axon Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 Wall Street's main indexes advanced on Wednesday, aided by a dovish turn by Japan's top policymaker after a surprise interest rate hike last week which partly sparked heavy volatility in global markets.
A
A
C
F
I
T
U
U
L

U.S. STOCKS Ralph Lauren, Illumina, Disney

BUZZ-U.S. STOCKS ON THE MOVE-Ralph Lauren, Illumina, Disney Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 U.S. stock index futures jumped on Wednesday as risk appetite returned after a steep selloff earlier in the week, and cautious comments on interest-rate hikes by an influential Bank of Japan policymaker.
A
C
F
I
T
U
G
L
S
A

Illumina up after Q2 results; Citigroup raises PT

BUZZ-Illumina up after Q2 results; Citigroup raises PT ** Shares of gene-sequencing machine maker Illumina ILMN.O up ~2% at $118.81 premarket ** Citigroup raises PT to $155 from $140, citing increased visibility on margins after, late-Tuesday, co posted Q2 results ** Co expects sales from its core segment to decline 2% to 3%, compared to the previous year over softened instrument demand in a constrained funding environment ** ILMN sees FY per-share profit of $3.80 to $3.95 for its core segment v
C
I

Illumina Inc reports results for the quarter ended in June - Earnings Summary

Illumina Inc reports results for the quarter ended in June - Earnings Summary Illumina Inc ILMN.OQ reported quarterly adjusted earnings of 36 cents​​ per share for the quarter ended in June, higher than the same quarter last year, when the company reported EPS of 32 cents. The mean expectation of twenty analysts for the quarter was for earnings of 90 cents per share.
I

Illumina expects full-year sales from core segment to decline on biotech funding crunch

Illumina expects full-year sales from core segment to decline on biotech funding crunch Aug 6 (Reuters) - Gene sequencing machine maker Illumina ILMN.O on Tuesday forecast 2024 sales from its core segment to decline, a sign that subdued demand for its instruments used in genetic tests could extend further into the year. Illumina has seen sluggish demand for its tools and services, used to develop therapies and vaccines, from key markets such as China and cautious spending from its customers such
I

Illumina Q2 Adjusted EPS USD 0.36 Vs. IBES Estimate USD 0.9

BRIEF-Illumina Q2 Adjusted EPS USD 0.36 Vs. IBES Estimate USD 0.9 Aug 06 (Reuters) - Illumina Q2 revenue USD 1,112 million vs. IBES estimate USD 1,080 million. Q2 gross margin 64.8% Q2 adjusted gross margin 69% Q2 adjusted EBIT margin 7.6% Q2 adjusted net income USD 57 million vs. IBES estimate USD 141.6 million Q2 EBIT margin -147.2% Q2 EPS USD -1
I

10x Genomics advances after Jefferies upgrades to 'buy'

BUZZ-10x Genomics advances after Jefferies upgrades to 'buy' ** Medical equipment maker 10x Genomics' TXG.O shares gain 6.5% to $17.79 premarket ** Brokerage Jefferies upgrades to "buy" from "hold" on longer term confidence in company's single-cell research unit, given its continued utility in areas like oncology research ** Investors under-appreciate incumbency in fields requiring technological consistency, brokerage says, adding that TGX technology superior vs competitors based on recent studi
I

Oracle CEO Safra Catz to depart Walt Disney board

Oracle CEO Safra Catz to depart Walt Disney board July 19 (Reuters) - Walt Disney DIS.N said on Friday that Oracle ORCL.N chief executive Safra Catz is departing the entertainment company's board after six years. Catz was elected to Disney's board in 2017 along with Illumina Inc's ILMN.O former CEO Francis deSouza, at a time when the company was looking to acquire Twenty-First Century Fox Inc's media empire.
I

U.S. STOCKS Pure Cycle, Tesla, Five9

BUZZ-U.S. STOCKS ON THE MOVE-Pure Cycle, Tesla, Five9 Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 The Nasdaq and the S&P 500 fell from record highs on Thursday, weighed by megacap stocks, as investors favored small-caps after a softer-than-expected inflation reading bolstered hopes that the U.S.
A
A
B
C
C
C
F
I
P
P
P
T
V
D
W
U
U
E

Nasdaq top and bottom performing stocks at about 12:01 p.m. EDT

BUZZ - Nasdaq top and bottom performing stocks at about 12:01 p.m. EDT Nasdaq 100 .NDX Top Performers Percent Change CoStar Group Inc CSGP.OQ +4.5% Dollar Tree Inc DLTR.OQ +4.4% Moderna Inc MRNA.OQ +4.0% Illumina Inc ILMN.OQ +3.7% Cognizant Technology Solutions Corp CTSH.OQ +3.4% Bottom Performers Percent Change Tesla Inc TSLA.OQ -6.4% Arm Holdings PLC ARM.OQ -5.6% NVIDIA Corp NVDA.OQ -4.7% Lam Research Corp LRCX.OQ -4.5% Micron Technology Inc MU.OQ -4.3% The Nasdaq 100 .NDX lost 415.31 points,
C
I
M
N
T
D
L
U
C

Nvidia leads Nasdaq and S&P 500 to record high closes

US STOCKS-Nvidia leads Nasdaq and S&P 500 to record high closes S&P 500 crosses 5,600 mark for first time TSMC up on strong Q2 revenue growth Intuit to cut about 1,800 jobs; shares fall S&P 500 +1.02%, Nasdaq +1.18%, Dow +1.09% Updates with price moves, volume By Noel Randewich and Ankika Biswas July 10 (Reuters) - The Nasdaq and S&P 500 rallied to record high closes on Wednesday, fueled by gains in Nvidia and other Wall Street heavyweights ahead of inflation data and quarterly earnings reports
A
I
I
M
N
A
U
U

Nvidia leads Nasdaq and S&P 500 to record high closes

US STOCKS-Nvidia leads Nasdaq and S&P 500 to record high closes S&P 500 crosses 5,600 mark for first time TSMC up on strong Q2 revenue growth Intuit to cut about 1,800 jobs; shares fall Updates with market close By Noel Randewich and Ankika Biswas July 10 (Reuters) - The Nasdaq and S&P 500 ra llied to record high closes on Wednesday, fueled by gains in Nvidia and other Wall Street heavyweights ahead of inflation data and quarterly earnings reports due this week.
A
I
I
M
N
U
U

Nasdaq top and bottom performing stocks at about 03:45 p.m. EDT

BUZZ - Nasdaq top and bottom performing stocks at about 03:45 p.m. EDT Nasdaq 100 .NDX Top Performers Percent Change Illumina Inc ILMN.OQ +5.3% Walgreens Boots Alliance Inc WBA.OQ +4.5% Microchip Technology Inc MCHP.OQ +4.0% Micron Technology Inc MU.OQ +3.9% ON Semiconductor Corp ON.OQ +3.7% Bottom Performers Percent Change CrowdStrike Holdings Inc CRWD.OQ -3.1% Intuit Inc INTU.OQ -3.0% DoorDash Inc DASH.OQ -3.0% Atlassian Corp TEAM.OQ -2.6% MongoDB Inc MDB.OQ -1.5% The Nasdaq 100 .NDX gained 20
I
I
M
W
M
O
U
A
C

Nvidia leads Nasdaq and S&P 500 to record highs

RPT-US STOCKS-Nvidia leads Nasdaq and S&P 500 to record highs S&P 500 crosses 5,600 mark for first time TSMC up on strong Q2 revenue growth Intuit to cut about 1,800 jobs; shares fall Indexes: S&P 500 +0.69%, Nasdaq +0.99%, Dow +0.48% Repeats to fix format, no other changes By Noel Randewich and Ankika Biswas NEW YORK, July 10 (Reuters) - The Nasdaq and S&P 500 h it record highs on Wednesday fueled by gains in Nvidia and other Wall Street heavyweights ahead of inflation data and quarterly earnin
A
I
I
M
N
U
U



Условия

Попул. активы

Правовая оговорка: Компании группы XM Group предоставляют только услуги по исполнению сделок и доступ к нашей торговой онлайн-среде, в которой пользователи могут просматривать и (или) пользоваться материалами, доступными на вебсайте либо доступными по ссылкам с данного сайта на другие. Предоставление доступа к онлайн-среде не меняет сути предоставляемых услуг и не расширяет их. Такой доступ и пользование материалами предоставляются с учетом:(i) «Условий и положений»; (ii) «Предупреждений о рисках» и (iii) полного текста «Правовой оговорки». Следовательно, подобные материалы предоставляются лишь в качестве информации общего характера. В частности, просим Вас иметь в виду, что материалы, содержащиеся в нашей торговой онлайн-среде, не являются ни просьбой осуществить какие-либо транзакции на финансовых рынках, ни предложением к осуществлению подобных транзакций. Торговля на любом финансовом рынке подразумевает большой риск потери Вашего капитала.

Все материалы, опубликованные в нашей торговой среде, предоставляются только в образовательных или информационных целях и не содержат (и не должны рассматриваться как содержащие) финансовых, инвестиционных или торговых рекомендаций, а также информации о стоимости наших услуг по предоставлению доступа к рынкам, либо предложения или содействия в проведении транзакций по какому-либо финансовому инструменту или по незапрашиваемым финансовым услугам по отношению к Вам.

Любые материалы на данном вебсайте, созданные третьими лицами, а также материалы, подготовленные XM, такие как мнения экспертов, новости, исследования, анализ, котировки и другая информация, а также ссылки на сторонние сайты предоставляются в виде «как есть», как рыночная информация общего характера, и не являют собой рекомендации по инвестициям. Принимая во внимание то, что любые материалы рассматриваются как инвестиционное исследование, Вам следует учесть и принять тот факт, что никакие материалы не подготавливались и не предназначались к использованию в соответствии с правовыми нормами, способствующими независимости инвестиционных исследований. Следовательно, материалы следует рассматривать как материалы рекламного характера согласно соответствующим законам и правовым нормам. Рекомендуем Вам прочесть и уяснить для себя положения наших «Уведомления о субъективном инвестиционном исследовании» и «Предупреждения о рисках» в отношении приведённой выше информации. С этими документами можно ознакомиться здесь.

Предупреждение о риске. Вы рискуете потерять свой капитал. Торговля маржинальными продуктами подходит не всем инвесторам. Пожалуйста, ознакомьтесь с нашим Предупреждением о рисках.